Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurovascular and Mitochondrial Mechanisms of Transcranial Photobiomodulation in Vascular Mild Cognitive Impairment

NCT07651787 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT07651787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07651787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurovascular and Mitochondrial Mechanisms of Transcranial Photobiomodulation in Vascular Mild Cognitive Impairment
Lead sponsor
University of Oklahoma
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2025
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloid pathology, mild cognitive impairment (mci)